CLINICAL_TRIALS
trial_result
· 2020-10-14
Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of SYNB1020 [Phase 1, Phase 2]
Summary
Phase 1/2 trial update for SYNB1020 focusing on safety, tolerability, and pharmacodynamics in cirrhosis has terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Synlogic | Conditions: Cirrhosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-10-14